Pharmaceuticals Events - Ernst & Young - United States

Global Pharmaceutical Center events

Webcast: IFRS convergence for the pharmaceutical industry - Part I

In conjunction with the PhRMA Accounting and Reporting subcommittee, we are pleased to offer the first of two webcasts on IFRS convergence for the pharmaceutical industry. Discussions will focus on tackling the challenges of IFRS conversions from both a project and change management perspective and provide leading practices and lessons learned on converting to IFRS. Register for our upcoming webcast on 9 March at 12:00pm ET.

Upcoming events 

• 15th Annual International Russian Pharmaceutical Forum
  19 - 21, May 2009,
  Saint-Petersburg, Russia
  www.adamsmithconferences.com 
  
  Hosted by Adam Smith Conferences, the 15th annual forum is one of the most significant events in the Russian pharmaceutical industry. The 50-plus strong speaker faculty is represented by top executives from leading companies working in the Russian pharmaceutical sector.

• International Pharmaceutical Regulatory and Compliance Congress
  28 - 29, May 2009,
  Rome, Italy
  www.InternationalPharmaCongress.com 
  
  Ernst & Young is proud to be a lead sponsor of the third annual International Pharmaceutical Regulatory and Compliance Congress. This premier event will bring together leading pharmaceutical regulatory and compliance professionals to network and share insights on significant topics, including compliance in a tough economy, fraud and clinical trials in emerging markets and FCPA issues.

• La Baule 2009 - 7th World Investment Conference "Making Europe More Attractive and Competitive"
  3 - 5, June 2009,
  Paris, France
  www.labaulewic.org 

  More than 1,000 global business leaders will come together at this premier event to exchange ideas and design concrete proposals for enhancing Europe's attractiveness. This conference will also serve as an ideal marketplace for policymakers and investors seeking opportunities, innovation and partnerships.
  Ernst & Young will announce the results from its annual survey highlighting the attractiveness of Europe and its regions.

Past events 

• Windhover: Pharmaceutical Strategic Outlook 2009
  13 - 15, April 2009,
  New York, New York
  www.windhover.com
  

  This annual event, sponsored by Ernst & Young, will examine last year’s most important strategic alliances, look ahead to the coming year and provide insights on maximizing strategic alliance opportunities. Hear discussion on what’s next for the broader biopharma worlds – models that break down the walls between Big Pharma, biotech and specialty pharma pipelines, and open up the financing opportunities to much broader investment audiences.

• CBI 5th Annual Pharmaceutical and Biotech Accounting and Reporting Congress
  16 - 17, March 2009,
  Philadelphia, PA
  www.cbinet.com

  As a sponsor of this important annual event, Ernst & Young invites you to hear key leaders and representatives from the industry present insights on current and upcoming accounting and reporting practices specific to life sciences companies. Speakers will cover key topics such as changing regulations, technical accounting, auditing and financial reporting best practices and the specific challenges and requirements of pharmaceutical and biotech companies.

• Ernst & Young life sciences transfer pricing roundtable
  11, March 2009,
  Morristown, NJ
  

  Ernst & Young will be hosting the life sciences transfer pricing roundtable, a roundtable series focusing on the international tax challenges related to transfer pricing facing senior-level tax professionals in the life sciences industry. To foster discussion, interaction and open dialogue, participation will be limited to international tax professionals from select multinational life sciences companies.

  Questions and RSVP:
  Contact Elite Rubin or call 212-773-6792

• Webcast: Is the Obama administration good medicine for the drug, biotech and medtech industries?
  20 February 2009
  

  Hear a replay of our webcast with leaders from PhRMA, Biotechnology Industry Organization and AdvaMed on the impact of the new administration on life science industries.

• Adam Smith Conference’s 14th Annual Russian pharmaceutical forum
  20 - 22 May, St. Petersburg, Russia
  

  Ernst & Young is a sponsor of this forum, which will discuss the Foreign Corrupt Practices Act (FCPA) and pharmaceutical promotional practices. What is the FCPA and what is its scope? How is the pharmaceutical industry implicated in the statute? What are some of the risk areas? What are examples of its applicability? What are some of the preventive and remedial actions?

  Contact: www.russianpharma.com 

• International Pharmaceutical Regulatory and Compliance Congress
  6-7 June 2007
  Brussels, Belgium
  www.internationalpharmacongress.com

  Ernst & Young is proud to have sponsored the first annual International Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum. The event brought together global leaders in the pharmaceutical industry to discuss emerging issues, current trends, regulations, and enforcement initiatives. The program was highly interactive and offered several networking opportunities.

  John Smart and Ted Acosta from Ernst & Young presented, along with top executives from international pharmaceutical companies, regulators from countries around the world, and seasoned legal and compliance professionals.

  Additionally, the Ernst & Young Global Pharmaceutical Center launched Progressions 2007 at this event.

• Annual BIO conference
  6-9 May 2007
  Boston, US

• Risk Advisory roundtable
  20 April 2007
  Berlin, Germany

• Pharma CIO roundtable
  29 March 2007
  New York, US

• Pharma Sector Risk Advisory/Indirect Tax roundtable
  15-16 March 2007
  Boston, US

• Interpreting the emerging health policy agenda: webcast archive
  The Congressional agenda and its impact on biotechnology and pharmaceutical companies was the subject of the Thought Center webcast "A prescription for change" on 6 March 2007. If you missed the live webcast, watch the archived program in video format, where panelists discuss the hot issues around the emerging health policy agenda